Home » Topics » Regulatory

Regulatory
RSS

FDA approves Egrifta for lipodystrophy in HIV-infected patients

Nov. 12, 2010

FDA approves once-daily Kombiglyze XR tablets for type 2 diabetes

Nov. 8, 2010

Questcor Pharma's Acthar launched in U.S. for infantile spasms

Nov. 5, 2010

FDA approves Teflaro for CABP and ABSSSI in adults

Nov. 4, 2010

FDA approves Avanir's Nuedexta for treatment of pseudobulbar affect

Nov. 2, 2010

Sunovion receives FDA approval for its once-daily schizophrenia treatment Latuda

Oct. 29, 2010

FDA approves subcutaneous administration of Gamunex-C in primary immunodeficiency

Oct. 22, 2010

Twice-daily tramadol/acetaminophen approved in eight European countries

Oct. 15, 2010

Daiichi Sankyo launches gel formulation of Loxonin in Japan

Oct. 6, 2010

Baxter obtains approval in Austria for Preflucel influenza vaccine

Oct. 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...